• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, September 17, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Chemistry

Researcher gets $2.7 million grant to study seasonal and universal vaccination in aged populations

Bioengineer by Bioengineer
September 6, 2025
in Chemistry
Reading Time: 2 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

ATLANTA–Dr. Sang-Moo Kang, professor in the Institute for Biomedical Sciences at Georgia State University, has received a five-year, $2.7 million federal grant to study seasonal and universal vaccination in elderly populations with pre-existing immunity to influenza viruses.

The grant from the National Institutes of Health’s National Institute of Allergy and Infectious Diseases will be used to determine if a new universal vaccine that induces immunity using multiple influenza proteins will enhance the range and efficacy of cross protection against different influenza virus strains in adult and aged populations with or without pre-existing immunity.

“The outcomes in this project will be highly significant in the aspect of translational science and relevance to improve the cross protective efficacy of flu vaccination,” Kang said.

People age 65 and older are at high risk of developing serious flu-related complications if they become ill from the flu, some of which can be life-threatening and result in death, according to the Centers for Disease Control and Prevention.

Seasonal flu vaccines, which are based on a highly variable influenza protein called hemagglutinin, fail to provide effective cross protection against different types of influenza viruses. The efficacy of these vaccines is particularly low in aged populations, even among individuals with pre-existing immunity to influenza.

In aged populations, the impact of pre-existing immunity on the effectiveness of universal and seasonal vaccination and immunogenicity, the ability of therapeutic protein products to stimulate an immune response, are not well understood. Developing flu vaccination strategies that improve cross protective efficacy in young and aged hosts with pre-existing immunity is of high priority.

This project will test whether new universal vaccines that induce immunity to multiple influenza virus protein targets – M2 extracellular domain, hemagglutinin-stalk domains and neuraminidase – will improve the range and efficacy of cross protection against seasonal variants and pandemic potential flu viruses in adult and aged animals with or without pre-existing immunity.

###

For more information about the grant, visit https://reporter.nih.gov/search/tTuPNzr7l0C_u2PIGtc51A/project-details/10313001.

Media Contact
LaTina Emerson
[email protected]

Original Source

https://news.gsu.edu/2021/06/04/biomedical-sciences-researcher-gets-2-7-million-federal-grant-to-study-seasonal-and-universal-vaccination-in-aged-populations/

Tags: AgingGerontologyImmunology/Allergies/AsthmaInfectious/Emerging DiseasesMedicine/HealthPharmaceutical ScienceVaccines
Share12Tweet8Share2ShareShareShare2

Related Posts

blank

Photocatalytic RNA Profiling Enables Multi-Omics Analysis

September 16, 2025
blank

Rare Einstein Cross Unveiled: Astronomers Detect Fifth Image Uncovering Hidden Dark Matter

September 16, 2025

“Shaking Up Electronics: How ‘Wiggling’ Atoms Could Shrink Devices and Boost Efficiency”

September 16, 2025

Rethinking the Cosmological Constant

September 16, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    154 shares
    Share 62 Tweet 39
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    117 shares
    Share 47 Tweet 29
  • Physicists Develop Visible Time Crystal for the First Time

    67 shares
    Share 27 Tweet 17
  • Scientists Achieve Ambient-Temperature Light-Induced Heterolytic Hydrogen Dissociation

    48 shares
    Share 19 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Treating Anal Lesions Lowers Invasive Cancer Risk in HIV

Exploring Mild Cognitive Impairment and Cancer in Seniors

Individual vs. Group Early Start Denver Model Effectiveness

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.